BIOMARIN PHARMACEUTICAL INC ($BMRN)

1 tracked superinvestor hold BIOMARIN PHARMACEUTICAL INC (BMRN), worth $436M combined, led by Andreas Halvorsen. Smart money is accumulating BMRN as of the latest 13F filings.

Current price

$66.53

BiotechnologyNASDAQUS

+17.2%

1Y

BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage…

Market cap

$10.4B

P/E

30.03

Div yield

0.0%

Revenue YoY

12.9%

Analyst target

$92

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

1

tracked 13F / N-PORT funds

Combined value

$436M

disclosed long exposure

Tier-1 conviction

1

concentrated holders

Net this quarter

+1

1 buying · 0 selling

Smart money is net accumulating BMRN: 1 funds added or opened versus 0 trimming.

The smart-money take on BMRN

BIOMARIN PHARMACEUTICAL INC (BMRN) is held by 1 tracked funds worth $436M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.

The largest position belongs to Andreas Halvorsen at 1.2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

No tracked fund opened a new position this quarter; 1 added and 0 trimmed, a net add.

Superinvestors holding BMRN

InvestorMove% of their portfolioPosition value
1
Andreas Halvorsen

Viking Global Investors

Added1.2%$436M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Insiders filing to sell BMRN

1 insider filed SEC Form 144 for $1M of proposed sales in the last 90 days. A 144 is filed before the trade — see who else is selling.

InsiderSharesValueFiled
Davis George Eric17,557$1M2026-09-02

Frequently asked

Which superinvestors own BMRN?

1 tracked funds hold BIOMARIN PHARMACEUTICAL INC (BMRN), the largest being Andreas Halvorsen (Viking Global Investors) at 1.2% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling BMRN?

In the most recent 13F quarter, 1 tracked fund added or opened BMRN and 0 trimmed it.

How much BMRN do tracked funds hold?

Combined disclosed long exposure to BMRN across tracked superinvestors is $436M as of the Jun 2026 filings.

Stocks often held alongside BMRN

Get alerted when superinvestors trade $BMRN

One email when a tracked manager opens, adds to or files to sell a position — from Form 4, 13D and Form 144, not the 45-day-old 13F.

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Jun 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.